Literature DB >> 15019898

Skeletal muscle hemodynamics and endothelial function in patients after Fontan operation.

Kei Inai1, Yoshimasa Saita, Sho Takeda, Makoto Nakazawa, Hirotaka Kimura.   

Abstract

To elucidate the relation between exercise capacity and peripheral hemodynamics in patients after the Fontan operation, near-infrared spectroscopy was performed on the vastus lateralis muscle, and flow-mediated vasodilation of the brachial and posterior tibial arteries was done with high-resolution ultrasonography. In Fontan patients, diminished exercise capacity was related to a reduced blood flow supply and an attenuated post-exercise oxygen resaturation of the working skeletal muscle, which also was related to impaired endothelium-dependent vasodilation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019898     DOI: 10.1016/j.amjcard.2003.11.062

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  Assessment of vascular remodeling after the Fontan procedure using a novel very high resolution ultrasound method: arterial wall thinning and venous thickening in late follow-up.

Authors:  Taisto Sarkola; Edgar Jaeggi; Cameron Slorach; Wei Hui; Timothy Bradley; Andrew N Redington
Journal:  Heart Vessels       Date:  2012-02-14       Impact factor: 2.037

Review 2.  Exercise capacity and impact of exercise training in patients after a Fontan procedure: a review.

Authors:  Patrice Brassard; Elisabeth Bédard; Jean Jobin; Josep Rodés-Cabau; Paul Poirier
Journal:  Can J Cardiol       Date:  2006-05-01       Impact factor: 5.223

3.  Effect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of concept.

Authors:  Jonathan Rhodes; Ana Ubeda-Tikkanen; Mathieu Clair; Susan M Fernandes; Dionne A Graham; Carly E Milliren; Kevin P Daly; Mary P Mullen; Michael J Landzberg
Journal:  Int J Cardiol       Date:  2013-03-29       Impact factor: 4.164

4.  Exercise capacity in children and adolescents with corrected congenital heart disease.

Authors:  Gabriela Feltez; Christian Corrêa Coronel; Lúcia Campos Pellanda; Janice Luisa Lukrafka
Journal:  Pediatr Cardiol       Date:  2015-03-26       Impact factor: 1.655

5.  Platelet volume indices correlate to severity of heart failure and have prognostic value for both cardiac and thrombotic events in patients with congenital heart disease.

Authors:  Masaki Sato; Seiji Asagai; Gen Harada; Eriko Shimada; Kei Inai
Journal:  Heart Vessels       Date:  2022-06-27       Impact factor: 1.814

6.  Thromboembolic complications in Fontan patients: population-based prevalence and exploration of the etiology.

Authors:  L Idorn; A S Jensen; K Juul; J I Reimers; P I Johansson; K E Sørensen; S R Ostrowski; L Søndergaard
Journal:  Pediatr Cardiol       Date:  2012-07-28       Impact factor: 1.655

7.  Impact of spironolactone on endothelial function in patients with single ventricle heart.

Authors:  William T Mahle; Alicia Wang; Arshed A Quyyumi; Michael E McConnell; Wendy M Book
Journal:  Congenit Heart Dis       Date:  2009 Jan-Feb       Impact factor: 2.007

8.  Exercise prescription for patients with a Fontan circulation: current evidence and future directions.

Authors:  T Takken; H J Hulzebos; A C Blank; M H P Tacken; P J M Helders; J L M Strengers
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

9.  Effect of Inhaled Nitric Oxide on Blood Flow Dynamics in Patients After the Fontan Procedure Using Cardiovascular Magnetic Resonance Flow Measurements.

Authors:  Heiner Latus; Bettina Gerstner; Gunter Kerst; Axel Moysich; Kerstin Gummel; Christian Apitz; Juergen Bauer; Dietmar Schranz
Journal:  Pediatr Cardiol       Date:  2015-11-07       Impact factor: 1.655

Review 10.  Factors influencing adaptation and performance at physical exercise in complex congenital heart diseases after surgical repair.

Authors:  P P Bassareo; L Saba; P Solla; C Barbanti; A R Marras; G Mercuro
Journal:  Biomed Res Int       Date:  2014-04-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.